Certified by Founder Lodge
BioCentriq
United States - Newark, New Jersey
START UP
1 Disclosed Funding Rounds $29,200,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
BioCentriq is an established, highly collaborative, global cell therapy CDMO. The company has been successfully manufacturing drug products for use in human clinical trials since 2022. In Jun
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| January, 04 ,2024 | Series A | $29,200,000 |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Pryzm | $2,000,000 | (Aug 29, 2024)
Ancilia Biosciences | $4,200,000 | (Aug 29, 2024)
Melodi Health | $10,750,000 | (Aug 29, 2024)
Parry Labs | $80,000,000 | (Aug 29, 2024)
Agency | $2,600,000 | (Aug 29, 2024)
